Accordingly, tumor‐initiating cells (TICs) from prostate cancer showed higher PCK2 levels than the parental cells and PCK2 silencing reduced TIC numbers by affecting levels of reactive oxygen species and protein acetylation [19]. Here, PCK2 is linked to prostate carcinoma.